Physician
Appalachian Family Care, LLC
Appalachian Family Care, LLC was paid $202K by Medicaid between Jan 2018 and Jul 2024, across 10 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 75% of everything it billed.
33Billing provider infoAPPALACHIAN FAMILY CARE, LLC
VANSANT, VA 24656
VANSANT, VA 24656
33aNPI1053336636assigned 07/13/2006
33bProvider typeFamily Medicine Physician
28Total paid$202K
24GClaims5,941
24DCodes billed10
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Family Medicine Physician providers in Virginia
Rank by total paid#132 of 772
Median peer was paid$13K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 391 | $11K | |
| 2019 | 1,449 | $45K | |
| 2020 | 768 | $31K | |
| 2021 | 492 | $16K | |
| 2022 | 1,069 | $44K | |
| 2023 | 1,247 | $40K | |
| 2024incomplete | 525 | $16K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 75% | 3,386 | 2,842 | $151K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 8.5% | 602 | 538 | $17K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.2% | 230 | 221 | $15K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.6% | 693 | 446 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 422 | 376 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.1% | 387 | 248 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 69 | 68 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 14 | 14 | $523.11 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 13 | 13 | $213.47 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 125 | 108 | $191.26 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMINTON, FRANCES (PRESIDENT)